Breaking News Instant updates and real-time market news.

VZ

Verizon

$50.26

-0.01 (-0.02%)

, CMCSA

Comcast

$65.41

-0.39 (-0.59%)

06:50
10/07/16
10/07
06:50
10/07/16
06:50

FCC relaxes proposed broadband consumer privacy rules, WSJ reports

Federal telecommunications regulators offered a dialed-down version of their broadband consumer privacy rules after significant criticism of a prior version from internet providers and other firms, the Wall Street Journal reports. The new FCC regulations essentially would require broadband internet providers, such as Comcast (CMCSA, CMCSK) and Verizon (VZ) to obtain consumer approval before marketing sensitive information, such as a customer's web-browsing history, to a third party, the report added. Reference Link

VZ

Verizon

$50.26

-0.01 (-0.02%)

CMCSA

Comcast

$65.41

-0.39 (-0.59%)

CMCSK

Comcast

  • 20

    Oct

  • 26

    Oct

  • 07

    Nov

VZ Verizon
$50.26

-0.01 (-0.02%)

09/06/16
RHCO
09/06/16
NO CHANGE
Target $18
RHCO
Neutral
SunTrust sees 'limited' list of Twitter suitors, says activist action unlikely
SunTrust analyst Robert Peck reiterated his belief that Twitter (TWTR) is unlikely to sell itself in 2016 in a new note to investors, but noted that investors have asked him who would be interested if Twitter were open to a sale. While giving his opinion on potential acquirers - which he sees possibly including Google (GOOG), Facebook (FB), Apple (AAPL), Amazon (AMZN), Microsoft (MSFT), AT&T (T), Verizon (VZ), Disney (DIS), Fox (FOXA), and Alibaba (BABA) - Peck said the company's high price and "unique" asset limit the potential buyers and gave his view that a PE buyer is highly unlikely given the company's lack of free cash flow. Additionally, Peck thinks activist action at Twitter seems "extremely unlikely" despite "unsubstantiated investor conjecture" and media reports. The analyst keeps Neutral rating and $18 price target on Twitter shares.
09/19/16
WELS
09/19/16
NO CHANGE
WELS
Concerns about Frontier Communications leverage overdone, says Wells Fargo
Wells Fargo says that some investors have expressed concern about Frontier's leverage ratio. Specifically, the firm says there are some worries that if Frontier has difficulty integrating the Verizon (VZ) assets it purchased, it may trigger bank covenants. However, Wells says that Frontier's synergy realization and subscription outlook have improved since Q2. Wells adds that the company's dividend is "very secure neat-term," and it keeps an Outperform rating on the shares.
09/23/16
RHCO
09/23/16
NO CHANGE
RHCO
Yahoo hack is probably not a material adverse change, says SunTrust
After Yahoo (YHOO) reported that over 500M of its accounts had been hacked, SunTrust analyst Robert Peck thinks that the news is probably not a material adverse change, or MAC, that would jeopardize the company's acquisition by Verizon (VZ). He notes that the sales contract says that a MAC will not be triggered by "any failure by Yahoo to meet its internal or published projections, budgets, plans, or forecasts of its revenues, earnings, or other financial performance or results of operations." The analyst says that the hack "may be manageable," since a majority of the victims could be e-mail users who are sticky. He keeps a Neutral rating on Yahoo.
09/23/16
BOFA
09/23/16
NO CHANGE
Target $55
BOFA
Buy
BofA thinks Verizon deal stays on track despite Yahoo data breach
Bank of America Merrill Lynch analyst Justin Post said that Yahoo's (YHOO) disclosure of the massive data breach impacting over 500M of its users is clearly a negative for the company that could result in email account closures, but he does not anticipate a major impact on Yahoo's business related to this breach, citing as evidence the fact that he is not aware of any significant business impairment or financial liability related to security breaches at LinkedIn (LNKD) in 2012 and at eBay (EBAY) in 2014. Post adds that the Target (TGT) data breach, which did include credit card info, is not directly comparable to Yahoo's breach. For Verizon (VZ) to back out of its acquisition agreement, Post thinks the company would need to assume Yahoo acted in bad faith during negotiations and that the Yahoo asset is impaired or comes with significant liability, neither of which he sees as being the case. The analyst keeps a Buy rating on Yahoo and bumped his target on the shares to $55 from $53, citing an increased price target on Alibaba (BABA) that a peer at the firm recently set.
CMCSA Comcast
$65.41

-0.39 (-0.59%)

08/22/16
JPMS
08/22/16
NO CHANGE
JPMS
Overweight
DISH renewal a major positive for Rovi, says JPMorgan
JPMorgan analyst Sterling Auty said he views Rovi's (ROVI) newly-announced 10-year contract renewal with DISH Networks (DISH) as a "major positive" that should help Rovi's position to complete its renewal with Comcast (CMCSA), which is the only top 10 pay-TV provider not currently under contract with the company. The announcement language suggests pricing "somewhere just above" that given to AT&T (T) and the duration of the deal validates the longevity of the patent portfolio, said Auty, who keeps an Overweight rating on Rovi shares.
08/22/16
PIPR
08/22/16
NO CHANGE
Target $27
PIPR
Overweight
Piper Jaffray confident in Comcast signing with Rovi
Piper Jaffray analyst Michael Olson notes that Rovi (ROVI) announced a 10-year renewal with DISH (DISH) and while the terms were not disclosed, economics should be similar to recent deals, likely in the range of 21c-22c per subscriber per month. With DISH in the fold, nine of the ten major U.S. TV service providers now license Rovi guide patents, the analyst said, with Comcast (CMCSA; CMCSK) remaining the lone holdout. Olson believes discussions with Comcast are at the economic level, and is confident in Comcast signing, potentially in the first half of 2017. He reiterates an Overweight rating and $27 price target on Rovi's shares.
09/26/16
UBSW
09/26/16
NO CHANGE
Target $92
UBSW
Neutral
Consumer satisfaction with competitors has caught up to Netflix, says UBS
UBS analyst Doug Mitchelson said that the firm's Evidence Lab survey indicated that U.S. consumer satisfaction with Amazon Prime Video (AMZN) and Hulu - the joint venture owned by Time Warner (TWX), Comcast (CMCSA), 21st Century Fox (FOXA), and Disney (DIS) - has now caught up to Netflix (NFLX), advising that investors should "continue to monitor competitive threats closely" as Netflix leads the category but demand for consumer media time, attention and wallet has intensified. The analyst, who added that Netflix's "pricing power remains unclear" based on the firm's survey work, keeps a Neutral rating and $92 price target on Netflix shares.
09/27/16
PIVT
09/27/16
NO CHANGE
PIVT
Comcast should report 'strong' Q3 results, says Pivotal Research
Pivotal Research analyst Jeffrey Wlodarczak expects Comcast to report "strong" Q3 results, with flat video subscriber additions, a 330,000 increase in data subscribers, an Olympics-driven 17% increase in NBC revenue ,and a total, slightly below consensus EBITDA gain of 7%. The analyst says that the stock's valuation is "very attractive." He raised his price target on the name to $90 from $81 to reflect a transition to year-end 2017 estimates and reiterates a Buy rating.
CMCSK Comcast

07/11/16
OPCO
07/11/16
NO CHANGE
Target $70
OPCO
Outperform
Comcast remains 'most attractive' large-cap, says Oppenheimer
Oppenheimer analyst Timothy Horan says Comcast remains the "most attractive" large-cap for remainder of the year, with its shares offering attractive upside despite the "strong performance" year to date. The company's unsurpassed broadband and public Wi-Fi networks indicate "strong sub trends" in 2016-2017, the analyst tells investors in a research note. Furthermore, he points out that its advertising revenues are "strong" helped by Olympics and political advertising as well as Cable. Oppenheimer has an Outperform rating and $70 price target on the shares.

TODAY'S FREE FLY STORIES

EA

Electronic Arts

$112.62

-0.55 (-0.49%)

08:07
06/23/17
06/23
08:07
06/23/17
08:07
Recommendations
Electronic Arts analyst commentary  »

Electronic Arts price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALXN

Alexion

$126.23

2.65 (2.14%)

08:05
06/23/17
06/23
08:05
06/23/17
08:05
Hot Stocks
Alexion announces positive CHMP opinion for Soliris »

Alexion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ALGN

Align Technology

$149.69

0.27 (0.18%)

08:04
06/23/17
06/23
08:04
06/23/17
08:04
Recommendations
Align Technology analyst commentary  »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

TRMK

Trustmark

$31.67

-0.53 (-1.65%)

08:04
06/23/17
06/23
08:04
06/23/17
08:04
Downgrade
Trustmark rating change  »

Trustmark downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVEO

AVEO Oncology

$0.73

0.0281 (4.02%)

08:03
06/23/17
06/23
08:03
06/23/17
08:03
Hot Stocks
AVEO Oncology reports positive CHMP opinion for tivozanib as RCC treatment »

AVEO Oncolog announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CI

Cigna

$170.68

0.5 (0.29%)

, HUM

Humana

$237.00

0.79 (0.33%)

08:03
06/23/17
06/23
08:03
06/23/17
08:03
Recommendations
Cigna, Humana, Aetna, WellCare, Anthem, Health Net, Centene, Molina Healthcare, UnitedHealth analyst commentary  »

Jefferies says healthcare…

CI

Cigna

$170.68

0.5 (0.29%)

HUM

Humana

$237.00

0.79 (0.33%)

AET

Aetna

$152.98

0.88 (0.58%)

WCG

WellCare

$183.60

6.06 (3.41%)

ANTM

Anthem

$193.36

1.29 (0.67%)

HNT

Health Net

CNC

Centene

$83.00

2.88 (3.59%)

MOH

Molina Healthcare

$71.31

1.58 (2.27%)

UNH

UnitedHealth

$186.50

1.58 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

ZAYO

Zayo Group

$31.27

-0.54 (-1.70%)

08:03
06/23/17
06/23
08:03
06/23/17
08:03
Hot Stocks
Zayo Group selected by global webscale company for wavelength solution »

A global webscale company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSM

Williams-Sonoma

$47.18

0.48 (1.03%)

08:02
06/23/17
06/23
08:02
06/23/17
08:02
Hot Stocks
Williams-Sonoma to open expansive dual concept store in Seattle »

Williams Sonoma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRFT

Perficient

$17.55

0.15 (0.86%)

08:01
06/23/17
06/23
08:01
06/23/17
08:01
Hot Stocks
Perficient acquires Clarity Consulting in accretive deal »

Perficient announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

NSAT

Norsat

08:01
06/23/17
06/23
08:01
06/23/17
08:01
Hot Stocks
Norsat shareholders approve plan of arrangement with Hytera Communications »

Norsat announced that at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CATB

Catabasis Pharmaceuticals

$1.30

-0.01 (-0.76%)

08:00
06/23/17
06/23
08:00
06/23/17
08:00
Hot Stocks
Catabasis Pharmaceuticals to present results from MoveDMD trial at PPMD »

Catabasis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

P

Pandora

$7.80

0.29 (3.86%)

08:00
06/23/17
06/23
08:00
06/23/17
08:00
Options
Pandora call buyer realizes 8% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

BIIB

Biogen

$280.57

1.97 (0.71%)

, SSNLF

Samsung

08:00
06/23/17
06/23
08:00
06/23/17
08:00
Hot Stocks
Biogen's IMRALDI granted positive opinion by CHMP »

The Committee for…

BIIB

Biogen

$280.57

1.97 (0.71%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

08:00
06/23/17
06/23
08:00
06/23/17
08:00
General news
N.Y. FX Outlook: The dollar looks likely to remain on a neutral footing »

N.Y. FX Outlook: The…

FIT

Fitbit

$5.09

0.1 (2.00%)

07:59
06/23/17
06/23
07:59
06/23/17
07:59
Recommendations
Fitbit analyst commentary  »

Fitbit reorganization of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$32.66

-0.5 (-1.51%)

07:59
06/23/17
06/23
07:59
06/23/17
07:59
Technical Analysis
Technical View: Hain Celestial near 52-week low in pre-market, analyst actions »

The stock is down over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

MEI

Methode Electronics

$40.10

1.45 (3.75%)

07:54
06/23/17
06/23
07:54
06/23/17
07:54
Recommendations
Methode Electronics analyst commentary  »

Baird remains a buyer of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HNHPF

Hon Hai Precision

, TOSYY

Toshiba, also use TOSBF

$17.39

0.085 (0.49%)

07:53
06/23/17
06/23
07:53
06/23/17
07:53
Periodicals
Foxconn's Gou still sees 50% chance of landing Toshiba chip unit, DigiTimes says »

Foxconn (HNHPF) Chairman…

HNHPF

Hon Hai Precision

TOSYY

Toshiba, also use TOSBF

$17.39

0.085 (0.49%)

TOSBF

Toshiba, also use TOSYY

$2.88

-0.01 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$35.36

0.48 (1.38%)

07:53
06/23/17
06/23
07:53
06/23/17
07:53
Hot Stocks
AstraZeneca announces positive CHMP opinion for Faslodex »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

V

Visa

$93.95

-0.59 (-0.62%)

07:52
06/23/17
06/23
07:52
06/23/17
07:52
Recommendations
Visa analyst commentary  »

Visa a good idea for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CARA

Cara Therapeutics

$19.88

0.38 (1.95%)

07:51
06/23/17
06/23
07:51
06/23/17
07:51
Technical Analysis
Technical View: Cara Therapeutics at new 52-week high in pre-market »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jul

KMX

CarMax

$62.50

2.76 (4.62%)

07:51
06/23/17
06/23
07:51
06/23/17
07:51
Recommendations
CarMax analyst commentary  »

CarMax weakness on sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 29

    Jun

  • 30

    Jun

07:50
06/23/17
06/23
07:50
06/23/17
07:50
General news
Treasury Market Outlook: bonds are mixed while stocks are mostly lower »

Treasury Market Outlook:…

ENTA

Enanta

$37.11

1.77 (5.01%)

, ABBV

AbbVie

$73.18

1.84 (2.58%)

07:49
06/23/17
06/23
07:49
06/23/17
07:49
Hot Stocks
Enanta announces AbbVie recieves CHMP positive opinion for MAVIRET »

Enanta Pharmaceuticals…

ENTA

Enanta

$37.11

1.77 (5.01%)

ABBV

AbbVie

$73.18

1.84 (2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTIC

Otonomy

$17.75

0.25 (1.43%)

07:48
06/23/17
06/23
07:48
06/23/17
07:48
Recommendations
Otonomy analyst commentary  »

Otonomy trial has high…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.